Cargando…
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors
Background: Cardiovascular adverse events (CV-AEs) are considered critical complications in chronic myeloid leukemia (CML) patients treated with second- and third-generation tyrosine kinase inhibitors (TKIs). The aim of our study was to assess the correlation between metabolic profiles and CV-AEs in...
Autores principales: | Caocci, Giovanni, Deidda, Martino, Noto, Antonio, Greco, Marianna, Simula, Maria Pina, Mulas, Olga, Cocco, Daniele, Fattuoni, Claudia, Mercuro, Giuseppe, La Nasa, Giorgio, Cadeddu Dessalvi, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231160/ https://www.ncbi.nlm.nih.gov/pubmed/32326001 http://dx.doi.org/10.3390/jcm9041180 |
Ejemplares similares
-
The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
por: Deidda, Martino, et al.
Publicado: (2021) -
Metabolomic Approach to Redox and Nitrosative Reactions in Cardiovascular Diseases
por: Deidda, Martino, et al.
Publicado: (2018) -
Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection
por: Deidda, Martino, et al.
Publicado: (2019) -
Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis
por: Mulas, Olga, et al.
Publicado: (2021) -
Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection
por: Fazzini, Luca, et al.
Publicado: (2022)